U.S. Stock futures on Monday rose above optimism that talk of additional monetary stimulus is in progress and that the rollout of the Covid-19 vaccine could help stem the tide. Futures linked to the S&P 500 rose 0.7%, indicating that the broad-market index could reach a higher level after New …
Read More »The Covid-19 vaccine faces public concerns over rollout safety
Governments are moving toward approving the first vaccines to contain Covid-19, but public concerns about dosage safety are threatening to undermine those efforts. A survey by the University of Hamburg found that about 40% of respondents in seven European countries were hesitant or unwilling to prepare for the Covid-19 vaccine …
Read More »Covid-19 vaccine test from AstraZeneca, Ox Xford U.S. Can resume in
Federal health regulators have ruled out a leading Covid-19 vaccine candidate from AstraZeneca AZN in the U.S. Allowed the study to resume. 0.08% According to a person familiar with the matter and content reviewed by Wall Street Journal, PLC and Oxford University. U.S. The Food and Drug Administration wrapped up …
Read More »How Pfizer Partner Bioentech Coronavirus Vaccine Leads the Race
Mainz, Germany On a Friday in late January, Ugur Sahin received an email with bad news: A new study of a deadly new coronavirus in China suggests it is more contagious than previously thought. He believed the outbreak was likely to be an epidemic. The following Monday, the chief executive …
Read More »Pfizer will be able to apply for emergency use of the Covid-19 vaccine in late November
Pfizer Inc. P.F.E. -0.84% Said it may be ready to apply for emergency-use authorization of its Covid-19 vaccine by the end of November, believing that in late-stage human trials will yield positive efficacy and safety data, the first time it or any other leading Western vaccine developer This kind of …
Read More »